Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Urban environment during pregnancy and childhood and white matter microstructure in preadolescence in two European birth cohorts

  • Binter, Anne-Claire
  • Granés, Laura
  • Bannier, Elise
  • Castro, Montserrat de
  • Petricola, Sami
  • Fossati, Serena
  • Vrijheid, Martine
  • Chevrier, Cécile
  • El Marroun, Hanan
  • Nieuwenhuijsen, Mark J.
  • Saint-Amour, Dave
  • Tiemeier, Henning
  • Guxens Junyent, Mònica
Growing evidence suggests that urban environment may influence cognition and behavior in children, but the underlying pollutant and neurobiological mechanisms are unclear. We evaluated the association of built environment and urban natural space indicators during pregnancy and childhood with brain white matter microstructure in preadolescents, and examined the potential mediating role of air pollution and road-traffic noise. We used data of the Generation R Study, a population-based birth cohort in Rotterdam, the Netherlands (n = 2725; 2002-2006) for the primary analyses. Replication of the main findings was attempted on an independent neuroimaging dataset from the PELAGIE birth cohort, France (n = 95; 2002-2006). We assessed exposures to 12 built environment and 4 urban natural spaces indicators from conception up to 9 years of age. We computed 2 white matter microstructure outcomes (i.e., average of fractional anisotropy (FA) and mean diffusivity (MD) from 12 white matte tracts) from diffusion tensor imaging data. Greater distance to the nearest major green space during pregnancy was associated with higher whole-brain FA (0.001 (95%CI 0.000; 0.002) per 7 m increase), and higher land use diversity during childhood was associated with lower whole-brain MD (-0.001 (95%CI -0.002; -0.000) per 0.12-point increase), with no evidence of mediation by air pollution nor road-traffic noise. Higher percentage of transport and lower surrounding greenness during pregnancy were associated with lower whole-brain FA, and road-traffic noise mediated 19% and 52% of these associations, respectively. We found estimates in the same direction in the PELAGIE cohort, although confidence intervals were larger and included the null. This study suggests an association between urban environment and white matter microstructure, mainly through road-traffic noise, indicating that greater access to green space nearby might promote white matter development., We gratefully acknowledge the contribution of the children and parents, general practitioners, hospitals, midwives and pharmacies in Rotterdam for their participation in the Generation R Study. The Generation R Study is conducted by the Erasmus Medical Center in close collaboration with the School of Law and Faculty of Social Sciences of the Erasmus University Rotterdam, Rotterdam; the Municipal Health Service Rotterdam Area, Rotterdam; the Rotterdam Homecare Foundation, Rotterdam; and the Stichting Trombosedienst and Artsenlaboratorium Rijnmond (STAR-MDC), Rotterdam. The general design of the Generation R Study is made possible by financial support from the Erasmus Medical Center, Rotterdam; the Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw); the Netherlands Organization for Scientific Research (NWO); and the Ministry of Health, Welfare and Sport. Air pollution exposure assessment was made possible by funding from the European Community's Seventh Framework Program (Grant Agreement no. 211250, Grant Agreement no. 243406). In addition, the study was made possible by financial support from the ZonMw (Geestkracht Program 10.000.1003 and TOP 40-00812-98-11021). Supercomputing resources for neuroimaging data processing were provided by the Dutch Organization for Scientific Research (NWO, Cartesius/Snellius). Dr. El Marroun was supported by Stichting Volksbond Rotterdam, the Netherlands Organization for Scientific Research (NWO) Aspasia grant (No: 015.016.056), and the European Union's Horizon Research and Innovation Program (HappyMums, Grant Agreement No: 101057390. We are grateful to the gynecologists, obstetricians, ultra-sonographers, midwives, pediatricians, and families who participated in the PELAGIE cohort study. The PELAGIE cohort has been funded by Inserm (since the beginning), the French Ministries of Health (2003–2004), Labor (2002–2003), and Research (ATC 2003–2004), the French National Institute for Public Health Surveillance (InVS, 2002–2006), the National Agency for Research (ANR, 2005–2008, 2010–2012, 2015–2019), the French Agency for Environmental Health Safety (Afsset/ANSES, 2007–2009, 2009–2012), the French Agency for Drug Safety (2013–2017), the Fondation de France (2014–2017, 2015–2018, 2017–2021), the French Ministry of Ecology (PNRPE 2014–2016), the Research Institute of Public Health (IResP 2011–2014), and the following European programs: Hi-WATE 2007–2009, ENRIECO 2008–2010, and OBERON 2019–2023. MRI data acquisition was performed at the Neurinfo MRI research facility of the University of Rennes I. Neurinfo is granted by the European Union (FEDER), the French State, the Brittany Council, Rennes Metropole, INRIA, Inserm, and the University Hospital of Rennes. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No 874583, Advancing Tools for Human Early Lifecourse Exposome research and Translation (ATHLETE). This publication reflects only the authors' view and the European Commission is not responsible for any use that may be made of the information it contains. The geocodification of the addresses and the estimation of the air pollutants of the Dutch study participants was done within the framework of a project funded by the Health Effects Institute (HEI) (Assistance Award No. R-82811201). L.G. was funded by a Rio Hortega fellowship (CM22/00011) and M.G. by a Miguel Servet II fellowship (CPII18/00018) both awarded by the Spanish Institute of Health Carlos III We acknowledge support from the European Union's Horizon 2020 research and innovation program under grant agreements No 824989 (EUCAN-Connect), and No 733206 (LifeCycle project). ISGlobal acknowledges support from the grant CEX2018-000806-S funded by MCIN/AEI/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Ambient air temperature exposure and foetal size and growth in three European birth cohorts

  • Essers, Esmée
  • Granés, Laura
  • Delaney, Scott
  • Ballester, Joan
  • Santos, Susana
  • Petricola, Sami
  • Yang, Tiffany C.
  • Fernández-Somoano, Ana
  • Bereziartua, Ainhoa
  • Ballester Díez, Ferran
  • Tardón, Adonina
  • Tardón, Adonina
  • Vrijheid, Martine
  • Lertxundi, Aitana
  • McEachan, Rosemary R.C.
  • El Marroun, Hanan
  • Tiemeier, Henning
  • Iñiguez, Carmen
  • Guxens Junyent, Mònica
Introduction: Ambient air temperature may affect birth outcomes adversely, but little is known about their impact on foetal growth throughout pregnancy. We evaluated the association between temperature exposure during pregnancy and foetal size and growth in three European birth cohorts. Methods: We studied 23,408 pregnant women from the English Born in Bradford cohort, Dutch Generation R Study, and Spanish INMA Project. Using the UrbClimTM model, weekly ambient air temperature exposure at 100x100m resolution at the mothers' residences during pregnancy was calculated. Estimated foetal weight, head circumference, and femur length at mid and late pregnancy and weight, head circumference, and length at birth were converted into standard deviation scores (SDS). Foetal growth from mid to late pregnancy was calculated (grams or centimetres/week). Cohort/region-specific distributed lag non-linear models were combined using a random-effects meta-analysis and results presented in reference to the median percentile of temperature (14 °C). Results: Weekly temperatures ranged from -5.6 (Bradford) to 30.3 °C (INMA-Sabadell). Cold and heat exposure during weeks 1-28 were associated with a smaller and larger head circumference in late pregnancy, respectively (e.g., for 9.5 °C: -1.6 SDS [95 %CI -2.0; -0.4] and for 20.0 °C: 1.8 SDS [0.7; 2.9]). A susceptibility period from weeks 1-7 was identified for cold exposure and a smaller head circumference at late pregnancy. Cold exposure was associated with a slower head circumference growth from mid to late pregnancy (for 5.5 °C: -0.1 cm/week [-0.2; -0.04]), with a susceptibility period from weeks 4-12. No associations that survived multiple testing correction were found for other foetal or any birth outcomes. Conclusions: Cumulative exposure to cold and heat during pregnancy was associated with changes in foetal head circumference throughout gestation, with susceptibility periods for cold during the first pregnancy trimester. No associations were found at birth, suggesting potential recovery. Future research should replicate this study across different climatic regions including varying temperature profiles., The Generation R Study is conducted by the Erasmus Medical Center in close collaboration with the Faculty of Social Sciences of the Erasmus University Rotterdam, the Municipal Health Service Rotterdam area, Rotterdam, the Rotterdam Homecare Foundation, Rotterdam, and the Stichting Trombosedienst & Artsenlaboratorium Rijnmond (STAR- MDC), Rotterdam. We gratefully acknowledge the contribution of children and parents, general practitioners, hospitals, midwives, and pharmacies in Rotterdam. The general design of the Generation R Study is made possible by financial support from the Erasmus Medical Center, Rotterdam; the Erasmus University Rotterdam; the Netherlands Organization for Health Research and Development (ZonMw); the Netherlands Organization for Scientific Research (NWO); and the Ministry of Health, Welfare and Sport. Susana Santos is supported by the European Union's Horizon Europe Research and Innovation Programme under the Marie Sklodowska-Curie Postdoctoral Fellowship Grant Agreement No. 101109136 (URBANE). Dr. Hanan El Marroun was supported by Stichting Volksbond Rotterdam, the Netherlands Organization for Scientific Research (NWO) Aspasia grant (No: 015.016.056), and the European Union's Horizon 2020 Research and Innovation Program (HappyMums, Grant Agreement No: 101057390). The INMA Project is funded by grants from Instituto de Salud Carlos III (Red INMA G03/176, CB06/02/0041, FIS-FEDER: PI03/1615, PI04/1509, PI04/2018, PI04/1112, PI04/1931, PI05/1079, PI05/1052, PI06/0867, PI06/1213, PI07/0314, PI09/02647, PI09/00090, PI09/02311, PI11/01007, PI11/02591, PI11/02038, PI13/1944, PI13/2032, PI13/02187, PI13/02429, PI14/00891, PI14/01687, PI16/1288, PI17/00663, PI18/00909, PI18/01142, PI20/01695); from the UE (FP7-ENV-2011 cod 282,957 and HEALTH.2010.2.4.5–1); European Union’s Horizon 2020 research and innovation programme ATHLETE project (grant agreement 874583); from Miguel Servet-FEDER (CP11/00178, CP15/00025, and CPII16/00051, CPII18/00018); from Generalitat Valenciana: FISABIO (UGP 15–230, UGP-15–244, and UGP-15–249); from the Alicia Koplowitz Foundation 2017; from CIBERESP; from Fundación Cajastur and Universidad de Oviedo; from the Department of Health of the Basque Government (2005111093, 2009111069, 2,013,111,089 and 2015111065); from the Provincial Government of Gipuzkoa (DFG06/002, DFG08/001 and DFG15/221); annual agreements with the municipalities of the Gipuzkoa study area (Zumarraga, Urretxu, Legazpi, Azkoitia y Azpeitia y Beasain); and from Generalitat de Catalunya-CIRIT 1999SGR 00241. We received funding from the Agence Nationale de Securite Sanitaire de l’Alimentation de l’Environnement et du Travail (EST-18 RF-25), acknowledge support from the grant CEX2018-000806-S funded by MCIN/AEI/10.13039/501100011033 and support from the Generalitat de Catalunya through the CERCA Program. Laura Granés was funded by a Rio Hortega fellowship (CM22/00011) awarded by the Spanish Institute of Health Carlos III. Scott Delaney’s research contribution reported in this publication was supported by the National Institute of Environmental Health Sciences under Award Number R01ES034373 and by the National Institute on Aging under Award Number R01AG066793. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Joan Ballester acknowledges funding from the Spanish Ministry of Science and Innovation under grant agreement No RYC2018-025446-I (programme Ramón y Cajal).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Epigenetic timing effects on child developmental outcomes: a longitudinal meta-regression of findings from the Pregnancy And Childhood Epigenetics Consortium

  • Neumann, Alexander
  • Cosín Tomàs, Marta
  • Bustamante Pineda, Mariona
  • Maitre, Léa
  • Cecil, Charlotte A. M.
Background: DNA methylation (DNAm) is a developmentally dynamic epigenetic process; yet, most epigenome-wide association studies (EWAS) have examined DNAm at only one timepoint or without systematic comparisons between timepoints. Thus, it is unclear whether DNAm alterations during certain developmental periods are more informative than others for health outcomes, how persistent epigenetic signals are across time, and whether epigenetic timing effects differ by outcome. Methods: We applied longitudinal meta-regression models to published meta-analyses from the PACE consortium that examined DNAm at two timepoints-prospectively at birth and cross-sectionally in childhood-in relation to the same child outcome (ADHD symptoms, general psychopathology, sleep duration, BMI, asthma). These models allowed systematic comparisons of effect sizes and statistical significance between timepoints. Furthermore, we tested correlations between DNAm regression coefficients to assess the consistency of epigenetic signals across time and outcomes. Finally, we performed robustness checks, estimated between-study heterogeneity, and tested pathway enrichment. Results: Our findings reveal three new insights: (i) across outcomes, DNAm effect sizes are consistently larger in childhood cross-sectional analyses compared to prospective analyses at birth; (ii) higher effect sizes do not necessarily translate into more significant findings, as associations also become noisier in childhood for most outcomes (showing larger standard errors in cross-sectional vs prospective analyses); and (iii) DNAm signals are highly time-specific, while also showing evidence of shared associations across health outcomes (ADHD symptoms, general psychopathology, and asthma). Notably, these observations could not be explained by sample size differences and only partly to differential study-heterogeneity. DNAm sites changing associations were enriched for neural pathways. Conclusions: Our results highlight developmentally-specific associations between DNAm and child health outcomes, when assessing DNAm at birth vs childhood. This implies that EWAS results from one timepoint are unlikely to generalize to another. Longitudinal studies with repeated epigenetic assessments are direly needed to shed light on the dynamic relationship between DNAm, development and health, as well as to enable the creation of more reliable and generalizable epigenetic biomarkers. More broadly, this study underscores the importance of considering the time-varying nature of DNAm in epigenetic research and supports the potential existence of epigenetic "timing effects" on child health., The work of AN and CAMC was supported by the European Research Council (TEMPO; grant agreement No 101039672) and the European Union’s HorizonEurope Research and Innovation Programme (FAMILY, grant agreement No 101057529). The work of CAMC is further supported by the European Union’s Horizon 2020 Research and Innovation Programme (EarlyCause, grant agreement No 848158; HappyMums, grant agreement No 101057390). CAMC and JFF are supported by the European Union’s Horizon Europe Programme (STAGE project, grant agreement no.101137146). This research was conducted while CAMC was a Hevolution/AFAR New Investigator Awardee in Aging Biology and Geroscience Research. LST was supported by the CAPICE (Childhood and Adolescence Psychopathology: unravelling the complex etiology by a large Interdisciplinary Collaboration in Europe) project, the European Union’s Horizon 2020 research and innovation program, Marie Sklodowska Curie Actions – MSCA-ITN-2016 – Innovative Training Networks under grant agreement number 721567. SJL was supported in part by the Intramural Research Program of the NIH (NIEHS Z01 ES49019). SEH and CMP were partly supported by The Norwegian Research Council no 262700 and the Norwegian Cancer Society project no 244291. See additional file 3 for cohort-specific funding.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Early-life stress and the gut microbiome: A comprehensive population-based investigation

  • Mulder, Rosa H
  • Kraaij, Robert
  • Schuurmans, Isabel K.
  • Francés Cuesta, Carlos
  • Sanz Herranz, Yolanda
  • Medina-Gomez, Carolina
  • Duijts, Liesbeth
  • Rivadeneira, Fernando
  • Tiemeier, Henning
  • Jaddoe, Vincent W V
  • Felix, Janine F.
  • Cecil, Charlotte A M
Early-life stress (ELS) has been robustly associated with a range of poor mental and physical health outcomes. Recent studies implicate the gut microbiome in stress-related mental, cardio-metabolic and immune health problems, but research on humans is scarce and thus far often based on small, selected samples, often using retrospective reports of ELS. We examined associations between ELS and the human gut microbiome in a large, population-based study of children. ELS was measured prospectively from birth to 10 years of age in 2,004 children from the Generation R Study. We studied overall ELS, as well as unique effects of five different ELS domains, including life events, contextual risk, parental risk, interpersonal risk, and direct victimization. Stool microbiome was assessed using 16S rRNA sequencing at age 10 years and data were analyzed at multiple levels (i.e. α- and β-diversity indices, individual genera and predicted functional pathways). In addition, we explored potential mediators of ELS-microbiome associations, including diet at age 8 and body mass index at 10 years. While no associations were observed between overall ELS (composite score of five domains) and the microbiome after multiple testing correction, contextual risk - a specific ELS domain related to socio-economic stress, including risk factors such as financial difficulties and low maternal education - was significantly associated with microbiome variability. This ELS domain was associated with lower α-diversity, with β-diversity, and with predicted functional pathways involved, amongst others, in tryptophan biosynthesis. These associations were in part mediated by overall diet quality, a pro-inflammatory diet, fiber intake, and body mass index (BMI). These results suggest that stress related to socio-economic adversity - but not overall early life stress - is associated with a less diverse microbiome in the general population, and that this association may in part be explained by poorer diet and higher BMI. Future research is needed to test causality and to establish whether modifiable factors such as diet could be used to mitigate the negative effects of socio-economic adversity on the microbiome and related health consequences., The general design of The Generation R Study was made possible by financial support from the Erasmus MC, Rotterdam, the Erasmus University Rotterdam, the Netherlands Organization for Health Research and Development (ZonMW), the Netherlands Organization for Scientific Research (NWO), the Ministry of Health, Welfare and Sport and the Ministry of Youth and Families. The work of YS is supported by the European Commission – NextGenerationEU, through the CSIC Interdisciplinary Thematic Platform NEURO-AGING+. The work of RHM, YS, CFC, JFF, and CAMC is supported by the European Union’s Horizon 2020 Research and Innovation Programme (EarlyCause; grant agreement No 848158). CAMC is also supported by the European Union’s HorizonEurope Research and Innovation Programme (FAMILY, grant agreement No 101057529; HappyMums, grant agreement No 101057390) and the European Research Council (TEMPO; grant agreement No 101039672). This research was conducted while CAMC was a Hevolution/AFAR New Investigator Awardee in Aging Biology and Geroscience Research., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The exposome of brain aging across 34 countries

  • Legaz, Agustina
  • Moguilner, Sebastian
  • Barttfeld, Pablo
  • Cuadros Castro, Jhosmary
  • Galván Rial, Dante Sebastián
  • Migeot, Joaquín
  • Farina, Francesca R.
  • González-Gómez, Raúl
  • Salazar-Londoño, Salomón
  • de Souza Azzi, Tiago
  • Alcauter, Sarael
  • Amoruso, Lucía
  • Anghinah, Renato
  • Bakr, May
  • Behrens, María Isabel
  • Bruno, Martín A.
  • Cardona, Juan Felipe
  • Chen, Christopher
  • Colliot, Olivier
  • Custodio, Nilton
  • d'Acremont, Quentin
  • Debette, Stéphanie
  • Dzianok, Patrycja
  • Güntekin, Bahar
  • Huguet, Jordi
  • Jarne, Cecilia
  • Joliot, Marc
  • Karageorgiou, Elissaios
  • Khedr, Eman M.
  • Koopowitz, Sheri-Michelle
  • Kublik, Ewa
  • Lee, Jinkook
  • Aksman, Leon
  • López, Susanna
  • Margaretic, Paula
  • Matallana, Diana
  • Matis, Sophie
  • Miltiadous, Andreas
  • Novotni, Gabriela
  • Orio, Patricio
  • Parra, Mario A.
  • Reppermund, Simone
  • de Paula França Resende, Elisa
  • Salum, Giovanni Abrahão
  • Slachevsky, Andrea
  • Sosa Ortiz, Ana Luisa
  • Tadao Takada, Leonel
  • Toh, An Qi
  • Tzallas, Alexandros
  • Wen, Wei
  • Whelan, Robert
  • Yener, Görsev
  • Zegarra Valdivia, Jonathan Adrián
  • Alexoudi, Athanasia
  • Arshad, Faheem
  • Atta, Haisam
  • Ávila-Funes, José Alberto
  • Bonilla Santos, Jasmin
  • Bruña, Ricardo
  • Castelblanco-Toro, Sandra Milena
  • Chino Vilca, Brenda Nadia
  • Coronel-Oliveros, Carlos
  • Crivello, Fabrice
  • Cruzat, Josephine
  • Dellavale, Damián
  • Dhooge, Catherina
  • Di Caterina, Gaetano
  • Escudero, Javier
  • Esquivias Farias, Juan Manuel
  • Eze, Laz Ude
  • Evans, Tavia E.
  • Farombi, Temitope
  • Fernández, Alberto
  • Fittipaldi, Sol
  • Portillo, Florencia
  • Forno Martinic, Gonzalo
  • García, Adolfo M.
  • Garcia-Cordero, Indira
  • Gaurav, Rahul
  • Godoy, Maria Eugenia
  • González Campo, Cecilia
  • González Hernández, Alfredis
  • Hanoğlu, Lütfü
  • Hazelton, Jessica L.
  • Herzog, Rubén
  • Ikiz, Burcin
  • Njamnshi, Alfred Kongnyu
  • Landín-Romero, Ramón
  • López, María Eugenia
  • Maito, Marcelo Adrián
  • Medel, Vicente
  • Sepúlveda, Juan Pablo Morales
  • Ochoa Gómez, John Fredy
  • Ogbuagu, Chukwuanugo
  • de Oliveira, Maira Okada
  • Ozansoy, Mehmet
  • Palma-Espinosa, Javier
  • Hilal, Saima
  • Zhou, Juan Helen
  • Piña Escudero, Stefanie Danielle
  • Pitman, Julie Kay
  • Prado, Pavel
  • Ramírez González, Diego
  • Reyes, Pablo
  • Santamaría García, Hernando
  • Schröder, Johannes
  • Sitt, Jacobo Diego
  • Soliman, Radwa Kamel
  • Soto-Añari, Marcio
  • Thanissery, Nithin
  • Ito, Lucas Toshio
  • Tsuchida, Ami
  • Tzourio, Christophe
  • Yırıkoğulları, Harun
  • Yokoyama, Jennifer S.
  • Aguillón, David
  • Miller, Bruce
  • Alladi, Suvarna
  • Jiang, Yang
  • Navarro, Arcadi
  • Babiloni, Claudio
  • Huepe Artigas, David
  • Piguet, Olivier
  • Valdes Sosa, Pedro Antonio
  • Mostert, Cyprian M.
  • Tahmasian, Masoud
  • Li, Peng
  • Hu, Kun
  • Genon, Sarah
  • Stein, Dan J.
  • Maestú, Fernando
  • Pievani, Michela
  • Salama, Mohamed
  • Brodaty, Henry
  • Sachdev, Perminder S.
  • Lawlor, Brian
  • Eyre, Harris A.
  • Miranda, J. Jaime
  • Baez, Sandra
  • Tagliazucchi, Enzo
  • Durán-Aniotz, Claudia
  • Hernandez, Hernan
  • Ibáñez, Agustín
The physical and social exposome affects human aging, and brain clocks may track its effects. However, most studies neglect multidomain exposures (physical, social and political) across diverse settings globally and their associations with brain aging. In this study, we characterized the associations between 73 country-level physical and social exposomal factors and multimodal brain age in 18,701 participants from 34 countries (healthy individuals and those with Alzheimer's disease, frontotemporal lobar degeneration or mild cognitive impairment). Exposome effects were assessed using generalized additive models and meta-analytic frameworks. Aggregated exposome models explained up to 15.5-fold more variance than individual exposures (delta Akaike information criterion (ΔAIC): 2,034-3,127). Physical exposome was primarily associated with accelerated structural brain aging (limbic, subcortical and cerebellar regions), whereas social exposome was more strongly associated with functional brain aging (frontotemporal and limbic networks). Exposome burden accounted for 3.3-9.1-fold higher risk of accelerated aging, exceeding effects of clinical diagnoses. Findings were out-of-sample validated in cross-sectional and longitudinal designs, remained consistent across clinical subgroups and persisted after adjustment for demographics, age correction bias, cognition, scanner type and data quality. The exposome accelerates brain aging in health and disease, underscoring the need to address physical, social and political inequities., A.L. is supported by a ReDLat-NIH postdoctoral position and an Atlantic Fellowship from the Global Brain Health Institute (GBHI). H.H. is supported by the Davos Alzheimer’s Collaborative. F.F. is supported by an Alzheimer’s Association Research Fellowship Grant (AARF-21-848281). S.A. is supported by IN212624, PAPIIT-DGAPA-UNAM IN208622 y SECIHTI CF-2019/6390. L.A. is supported by the European Union’s Horizon 2020 research and innovation program under Marie Sklodowska-Curie grant agreement number 101025814. M.I.B. is supported by National Institute on Drug Abuse 75N95022C00031: Genetics of Alzheimer’s Disease and Related Dementias in Latin America. M.I.B. is also co-investigator for SG-20-725707-ReDLat, Alzheimer’s Association, Multi-partner Consortium for Dementia Research in Latin America. O.C. is supported by the French government under management of Agence Nationale de la Recherche as part of the ‘France 2030’ program (reference ANR-23-IACL-0008, project PRAIRIE-PSAI), as part of the ‘Investissements d’avenir’ program (reference ANR-19-P3IA-0001, project PRAIRIE 3IA Institute and reference ANR-10-IAIHU-06, project Agence Nationale de la Recherche-10-IA Institut Hospitalo-Universitaire-6), and by the European Union’s Horizon Europe Framework Program (grant number 101136607, project CLARA). N.C. is supported by ReDLat-NIH (AG057234). S.D. is supported by a grant overseen by the French National Research Agency (ANR) as part of the France 2030 ‘Investment for the Future Programme’ through the SHIVA project (ANR-18-RHUS-0002) and through the Precision and Global Vascular Brain Health Institute, funded by the France 2030 IHU3 initiative (ANR-23-IAHU-0001). Computations were performed at the Bordeaux Bioinformatics Center (CBiB) and the CREDIM computer resources, University of Bordeaux. Funding support for additional computer resources has been provided to S.D. by the Fondation Claude Pompidou. C.C. is supported by the National Medical Research Council of Singapore. The i-Share study has received funding from the French National Agency (Agence Nationale de la Recherche (ANR)), via the Investment for the Future program (grant no. ANR-10-COHO-05 and no. ANR-18-RHUS-0002) and from the University of Bordeaux Initiative of Excellence (IdEX). P.D. is supported by Polish National Science Center (NCN) grant number 2018/31/N/HS6/03551. C.J. is supported by UNQ, Proyecto de I+D Res.745/25. E.K. is supported by the MES-CoBraD Project EU Horizon 2020 grant (ID: 965422) to the Neurological Institute of Athens. J.L. is supported by the US National Institute on Aging (NIA), National Institutes of Health (NIH) (R01AG051125 and U01AG064948). L.A. is supported by the Office of the Director, NIH, under award numbers S10OD032285, R01AG080473, RF1AG087965 and RF1AG088003. (The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.) J.H.Z. is supported by the Singapore National Medical Research Council, grant numbers NMRC/OFLCG19May-0035, HLCA23Feb-0004 and OFIRG24Jul-0049. S.L. is supported by the ‘BE FOR ERC 2023’ fellowship from Sapienza University of Rome. P.M. is supported by the Belmon Forum. G.N. would like to extend her gratitude to V. Aliji from the University Institute of Radiology-Skopje, North Macedonia, and the Neurophysiology team from the University Clinic of Neurology, Skopje, North Macedonia, for their cooperation. P.O. is supported by Proyecto Fondecyt 1241469, ANID, Chile, and Proyecto AFB240002, ANID, Chile. M.A.P. is supported by a BrainLat Seed Grant (BL-SRGP2020-020) awarded to M.A.P. and A.I. E.d.P.F.R. is supported by the NIA of the NIH (R21AG069252), the Alzheimer’s Association (GBHI_ALZ-18-534892) and the World Federation of Neurology. G.A.S.J. is supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq grant numbers 573974/2008-0 and 465550/2014-2); Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP grant numbers 2008/57896-8, 2013/08531-5, 2014/50917-0, 2020/06172-1, 2021/05332-8 and 2021/12901-9); the European Research Council (ERC grant numbers 337673 and 101057390); the UK Medical Research Council (MRC grant number MR/R022763/1); Ministério da Saúde (Decit/SECTICS/MS grant number 888379/2019, Portaria no. 1.949, 04/08/2020); and Banco Industrial do Brasil S/A (CISM grant). A.S. is supported by ANID/Fondap/15150012, ANID/Fondecyt/1231839, ANID/FONDEF/ID22I10251 and ANID/Proyectos de Exploración 13220082 and ReDLat (supported by NIA, NIH (R01 AG057234), the Alzheimer’s Association (SG-20-725707), the Tau Consortium and the GBHI) and by Alzheimer’s Association GBHI ALZ UK-20-639295. L.T.T. is supported by the NIH (ReDLat). J.C. is supported by ANID (FONDECYT Postdoctorado no. 3240042 and Proyectos de Exploración no. 13240170). R.H. is supported by the Spanish Ministerio de Ciencia, Innovación y Universidades (MICIU/AEI/10.13039/501100011033) through María de Maeztu project CEX2021-001164-M. G.F.M. is supported by ANID (Fondecyt Postdoctoral no. 3250669). A.M.G. is partially supported by the NIA of the NIH (R01AG075775, R01AG083799 and 2P01AG019724); ANID (FONDECYT Regular 1250317 and 1250091); DICYT-USACH (032351GDAS); Agencia Nacional de Promoción Científica y Tecnológica (01-PICTE-2022-05-00103); and the ReDLat, which is supported by the Fogarty International Center and the NIH, NIA (R01AG057234, R01AG075775, R01AG21051 and CARDA-NIH), the Alzheimer’s Association (SG-20-725707), the Rainwater Charitable Foundation’s Tau Consortium, the Bluefield Project to Cure Frontotemporal Dementia and the GBHI. I.G.-C. is supported by an AFTD Pathways for Hope Pilot Grant (2025-002). R.L.-R. is supported by a National Health and Medical Research Council (NHMRC) Investigator Grant (GNT2010064). M.E.L. is supported by I+D+i project PID2022-141524NA-I00, funded by MCIN/AEI/10.13039/501100011033. V.M. is supported by ANID/FONDECYT de Iniciación 11251578 and ANID/FONDECYT Exploración 13240170. D.R.G. is supported by Fellowship 1003248 from Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI). H.S.G. is supported by an NIH R01 grant (‘Social epigenetics of Alzheimer’s disease and related dementias in Latin American countries’ (1R01AG082056-01A1)), the GBHI and the Alzheimerʼs Association (‘Brain health in individuals with exposition to high violence in Colombia’ (GBHI ALZ UK-23-971135)). J.E. acknowledges support from the UKRI AI program and the Engineering and Physical Sciences Research Council, for the CHAI-EPSRC AI hub for Causality in Healthcare AI with real data (grant number EP/Y028856/1). J.D.S. is supported by Program Investissements d’avenir ANR-10-IAIHU-06. M.S.-A. is supported by CONCYTEC (contrato no. PE501082737-2023-PROCIENCIA). L.T.I. is supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP, grant number 2022/15880-5). A.T. is supported by Investment for the Future Programme France 2030 (grant no. ANR-18-RHUS-0002) and the France 2030 IHU3 initiative for the Precision and Global Vascular Brain Health Institute (grant ANR-23-IAHU-0001). Y.J. is supported by NIA, NIH P01AG078116 and P30AG072946. (Data curation was partially supported by NIH grant AG000986 and Department of Energy contract DE-AC05-00OR22725.) C.B. is supported by funds of the project ‘Rome Technopole’ from the call Piano Nazionale di Ripresa e Resilienza (PNRR), Mission 4, ‘Istruzione e Ricerca’, Component 2, ‘Investment 1.5’, granted by the European Union, Next Generation EU and the Italian Ministry of University and Research (grant agreement ECS00000024). J.B.S. is supported by CONADI-Universidad Cooperativa de Colombia. D.H. is supported by ANID/FONDECYT Regular number 1231117. O.P. is supported by an NHMRC of Australia program grant (GNT1037746) and a Leadership Fellowship (GNT2008020) and by the Australian Research Council Centre of Excellence in Cognition and its Disorders Memory Program (CE11000102). P.A.V.S. is supported by the National Key R&D Program of China (2024YFE and 0215100). S.G. is supported by the Deutsche Forschungsgemeinschaft (DFG, GE 2835/2–1 and GE 2835/9-1). D.J.S. was supported by the SAMRC. F.M. is supported by Spanish Ministry of Science PID2021-122979OB-C21. M.P. is supported by the IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli and acknowledges support from the Italian Ministry of Health (Ricerca Corrente). The principal investigator of ARWIBO is G. B. Frisoni, University Hospitals and University of Geneva, Geneva, Switzerland, and IRCCS Fatebenefratelli, the National Centre for Alzheimer’s and Mental Diseases, Brescia, Italy. ARWIBO is the result of efforts of many researchers of IRCCS Fatebenefratelli: G. Binetti, Neurobiology; L. Bocchio-Chiavetto, Neuropharmacology; M. Cotelli, Neuropsychology; C. Minussi, Neurophysiology; M. Gennarelli, Genetic Unit; R. Ghidoni, Proteomics Unit; and D. Moretti and O. Zanetti, Alzheimer’s Unit. Data collection and sharing for ARWIBO was supported by the Italian Ministry of Health under the following grant agreements: Ricerca Corrente IRCCS Fatebenefratelli, Linea di Ricerca 2; Progetto Finalizzato Strategico 2000−2001 ‘Archivio normativo italiano di morfometria cerebrale con risonanza magnetica (età 40+)’; Progetto Finalizzato Strategico 2000−2001 ‘Decadimento cognitivo lieve non dementigeno: stadio preclinico di malattia di Alzheimer e demenza vascolare. Caratterizzazione clinica, strumentale, genetica e neurobiologica e sviluppo di criteri diagnostici utilizzabili nella realtà nazionale’; Progetto Finalizzata 2002 ‘Sviluppo di indicatori di danno cerebrovascolare clinicamente significativo alla risonanza magnetica strutturale’; Progetto Fondazione CARIPLO 2005−2007 ‘Geni di suscettibilità per gli endofenotipi associati a malattie psichiatriche e dementigene’; ‘Fitness and Solidarietà’; and anonymous donors. M.S. is supported by the NIA (grant 1R01AG081305); Davos Alzheimer’s Collaborative grant DAC-GC-22240710.01; the Doha International Family Institute (grant OSRA6-G-202305-00052); and American University in Cairo Research Support Grant 2022. H.B. has received funding from the NHMRC. P.S.S. is supported by an NHMRC of Australia Investigator Grant (RG193540), an NHMRC CRE grant (RG203943) and an NIH grant (R01AG057531-03). The Sydney Memory and Ageing Study has been funded by three NHMRC program grants (ID350833, ID568969 and APP1093083). J.J.M. is supported by the Academy of Medical Sciences (NGR2/1210); the Alliance for Health Policy and Systems Research (2009/32034 and 2012/253750); Bloomberg Philanthropies (grant 46129, via University of North Carolina at Chapel Hill School of Public Health); FONDECYT via CIENCIACTIVA/CONCYTEC, the British Council, the British Embassy and the Newton-Paulet Fund (223-2018 and 224-2018); DFID/MRC/Wellcome Global Health Trials (MR/M007405/1); the Fogarty International Center (R21TW009982, D71TW010877, R21TW011740 and K01TW011478); Grand Challenges Canada (GMH-POC-0335-04); the International Development Research Center Canada (IDRC 106887 and 108167); the Inter-American Institute for Global Change Research (IAI CRN3036); the National Cancer Institute (NCI 1P20CA217231); the National Council for Scientific and Technological Development (CNPq Brasil 408523/2023-9); the NHMRC (2022036, 2022566 and 2044237); the National Heart, Lung, and Blood Institute (NHLBI HHSN268200900033C, 5U01HL114180 and 1UM1HL134590); the NIA (R01AG057531); the National Institute for Health and Care Research (NIHR150261, NIHR150287, NIHR303125 and NIHR306208); the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK K23DK135798); the National Institute of Mental Health (NIMH 1U19MH098780); NSW Health (H23/37663 and DG23/7050); the Medical Research Future Fund (MRRF 204223); the Swiss National Science Foundation (40P740-160366); UKRI BBSRC (BB/T009004/1); UKRI EPSRC (EP/V043102/1); UKRI MRC (MR/P008984/1, MR/P024408/1, MR/P02386X/1, MR/X004163/1 and MR/X020851/1); Wellcome (074833/Z/04/Z, 093541/Z/10/Z, 103994/Z/14/Z, 107435/Z/15/Z, 205177/Z/16/Z, 214185/Z/18/Z and 218743/Z/19/Z); the World Diabetes Foundation (WDF15-1224); and the World Health Organization (2021/1189041 and 2022/1249357). T.E. is supported by the William H. Gates Sr. Fellowship from the Alzheimer’s Disease Data Initiative and Alzheimer Nederland Project WE.03-2024-07. S.B. is supported by the GBHI, the Alzheimer’s Association, Alzheimer’s Society UK and Pilot Awards for Global Brain Health Leaders (grant GBHI ALZ UK- 25-1289623). E.T. is supported by ANID/FONDECYT Regular 1220995 (Chile), ‘Mapping and modeling healthy and pathological aging trajectories’ and FONDECYT Exploración 13240170 ‘Neurovascular pathways in aging and neurodegenerative diseases: integrating cardiovascular health and brain function’. C.D.-A. is supported by ANID/FONDECYT Regular 1210622, ANID/PIA/ANILLOS ACT210096, the Alzheimer’s Association (AARGD-24- 1310017), ANID/FOVI240065 and ANID/Proyecto Exploracion 13240170. A.I. is supported by grants from the ReDLat (supported by the Fogarty International Center, the NIH, NIA (R01 AG057234, R01 AG075775, R01 AG21051, R01 AG083799, CARDS-NIH and R01 AG057234), the Alzheimer’s Association (SG-20-725707), the Rainwater Charitable Foundation, the Bluefield Project to Cure Frontotemporal Dementia and the GHBI); ANID/FONDECYT Regular (1250091, 1210176 and 1220995); ANID/PIA/ANILLOS ACT210096; JPI JPND-Care, DISCeRN 2025: Health and Social Care Research with a Focus on the Moderate and Late Stages of Neurodegenerative Diseases; FONDEF ID20I10152 and ANID/FONDAP 15150012; Wellcome Trust award for BRAIN-CLIMA: Investigating the Combined Impact of Heat and Air Pollution on Blood−Brain Barrier Integrity and Brain Aging in Latin America (335293/Z/25/Z); and CliCBrain (Horizon ID: 101236426; https://doi.org/10.3030/101236426, Marie Skłodowska-Curie Actions)., With funding from the Spanish government through the "Maria de Maeztu Centre of Excellence" accreditation (CEX2021-001164-M)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Epigenetic timing effects on child developmental outcomes: a longitudinal meta-regression of findings from the Pregnancy And Childhood Epigenetics Consortium

  • Neumann, Alexander
  • Cosín Tomàs, Marta
  • Bustamante Pineda, Mariona
  • Maitre, Léa
  • Cecil, Charlotte A. M.
Background: DNA methylation (DNAm) is a developmentally dynamic epigenetic process; yet, most epigenome-wide association studies (EWAS) have examined DNAm at only one timepoint or without systematic comparisons between timepoints. Thus, it is unclear whether DNAm alterations during certain developmental periods are more informative than others for health outcomes, how persistent epigenetic signals are across time, and whether epigenetic timing effects differ by outcome. Methods: We applied longitudinal meta-regression models to published meta-analyses from the PACE consortium that examined DNAm at two timepoints-prospectively at birth and cross-sectionally in childhood-in relation to the same child outcome (ADHD symptoms, general psychopathology, sleep duration, BMI, asthma). These models allowed systematic comparisons of effect sizes and statistical significance between timepoints. Furthermore, we tested correlations between DNAm regression coefficients to assess the consistency of epigenetic signals across time and outcomes. Finally, we performed robustness checks, estimated between-study heterogeneity, and tested pathway enrichment. Results: Our findings reveal three new insights: (i) across outcomes, DNAm effect sizes are consistently larger in childhood cross-sectional analyses compared to prospective analyses at birth; (ii) higher effect sizes do not necessarily translate into more significant findings, as associations also become noisier in childhood for most outcomes (showing larger standard errors in cross-sectional vs prospective analyses); and (iii) DNAm signals are highly time-specific, while also showing evidence of shared associations across health outcomes (ADHD symptoms, general psychopathology, and asthma). Notably, these observations could not be explained by sample size differences and only partly to differential study-heterogeneity. DNAm sites changing associations were enriched for neural pathways. Conclusions: Our results highlight developmentally-specific associations between DNAm and child health outcomes, when assessing DNAm at birth vs childhood. This implies that EWAS results from one timepoint are unlikely to generalize to another. Longitudinal studies with repeated epigenetic assessments are direly needed to shed light on the dynamic relationship between DNAm, development and health, as well as to enable the creation of more reliable and generalizable epigenetic biomarkers. More broadly, this study underscores the importance of considering the time-varying nature of DNAm in epigenetic research and supports the potential existence of epigenetic "timing effects" on child health., The work of AN and CAMC was supported by the European Research Council (TEMPO; grant agreement No 101039672) and the European Union’s HorizonEurope Research and Innovation Programme (FAMILY, grant agreement No 101057529). The work of CAMC is further supported by the European Union’s Horizon 2020 Research and Innovation Programme (EarlyCause, grant agreement No 848158; HappyMums, grant agreement No 101057390). CAMC and JFF are supported by the European Union’s Horizon Europe Programme (STAGE project, grant agreement no.101137146). This research was conducted while CAMC was a Hevolution/AFAR New Investigator Awardee in Aging Biology and Geroscience Research. LST was supported by the CAPICE (Childhood and Adolescence Psychopathology: unravelling the complex etiology by a large Interdisciplinary Collaboration in Europe) project, the European Union’s Horizon 2020 research and innovation program, Marie Sklodowska Curie Actions – MSCA-ITN-2016 – Innovative Training Networks under grant agreement number 721567. SJL was supported in part by the Intramural Research Program of the NIH (NIEHS Z01 ES49019). SEH and CMP were partly supported by The Norwegian Research Council no 262700 and the Norwegian Cancer Society project no 244291. See additional file 3 for cohort-specific funding.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Ambient air temperature exposure and foetal size and growth in three European birth cohorts

  • Essers, Esmée
  • Granés, Laura
  • Delaney, Scott
  • Ballester, Joan
  • Santos, Susana
  • Petricola, Sami
  • Yang, Tiffany C.
  • Fernández-Somoano, Ana
  • Bereziartua, Ainhoa
  • Ballester Díez, Ferran
  • Tardón, Adonina
  • Tardón, Adonina
  • Vrijheid, Martine
  • Lertxundi, Aitana
  • McEachan, Rosemary R.C.
  • El Marroun, Hanan
  • Tiemeier, Henning
  • Iñiguez, Carmen
  • Guxens Junyent, Mònica
Introduction: Ambient air temperature may affect birth outcomes adversely, but little is known about their impact on foetal growth throughout pregnancy. We evaluated the association between temperature exposure during pregnancy and foetal size and growth in three European birth cohorts. Methods: We studied 23,408 pregnant women from the English Born in Bradford cohort, Dutch Generation R Study, and Spanish INMA Project. Using the UrbClimTM model, weekly ambient air temperature exposure at 100x100m resolution at the mothers' residences during pregnancy was calculated. Estimated foetal weight, head circumference, and femur length at mid and late pregnancy and weight, head circumference, and length at birth were converted into standard deviation scores (SDS). Foetal growth from mid to late pregnancy was calculated (grams or centimetres/week). Cohort/region-specific distributed lag non-linear models were combined using a random-effects meta-analysis and results presented in reference to the median percentile of temperature (14 °C). Results: Weekly temperatures ranged from -5.6 (Bradford) to 30.3 °C (INMA-Sabadell). Cold and heat exposure during weeks 1-28 were associated with a smaller and larger head circumference in late pregnancy, respectively (e.g., for 9.5 °C: -1.6 SDS [95 %CI -2.0; -0.4] and for 20.0 °C: 1.8 SDS [0.7; 2.9]). A susceptibility period from weeks 1-7 was identified for cold exposure and a smaller head circumference at late pregnancy. Cold exposure was associated with a slower head circumference growth from mid to late pregnancy (for 5.5 °C: -0.1 cm/week [-0.2; -0.04]), with a susceptibility period from weeks 4-12. No associations that survived multiple testing correction were found for other foetal or any birth outcomes. Conclusions: Cumulative exposure to cold and heat during pregnancy was associated with changes in foetal head circumference throughout gestation, with susceptibility periods for cold during the first pregnancy trimester. No associations were found at birth, suggesting potential recovery. Future research should replicate this study across different climatic regions including varying temperature profiles., The Generation R Study is conducted by the Erasmus Medical Center in close collaboration with the Faculty of Social Sciences of the Erasmus University Rotterdam, the Municipal Health Service Rotterdam area, Rotterdam, the Rotterdam Homecare Foundation, Rotterdam, and the Stichting Trombosedienst & Artsenlaboratorium Rijnmond (STAR- MDC), Rotterdam. We gratefully acknowledge the contribution of children and parents, general practitioners, hospitals, midwives, and pharmacies in Rotterdam. The general design of the Generation R Study is made possible by financial support from the Erasmus Medical Center, Rotterdam; the Erasmus University Rotterdam; the Netherlands Organization for Health Research and Development (ZonMw); the Netherlands Organization for Scientific Research (NWO); and the Ministry of Health, Welfare and Sport. Susana Santos is supported by the European Union's Horizon Europe Research and Innovation Programme under the Marie Sklodowska-Curie Postdoctoral Fellowship Grant Agreement No. 101109136 (URBANE). Dr. Hanan El Marroun was supported by Stichting Volksbond Rotterdam, the Netherlands Organization for Scientific Research (NWO) Aspasia grant (No: 015.016.056), and the European Union's Horizon 2020 Research and Innovation Program (HappyMums, Grant Agreement No: 101057390). The INMA Project is funded by grants from Instituto de Salud Carlos III (Red INMA G03/176, CB06/02/0041, FIS-FEDER: PI03/1615, PI04/1509, PI04/2018, PI04/1112, PI04/1931, PI05/1079, PI05/1052, PI06/0867, PI06/1213, PI07/0314, PI09/02647, PI09/00090, PI09/02311, PI11/01007, PI11/02591, PI11/02038, PI13/1944, PI13/2032, PI13/02187, PI13/02429, PI14/00891, PI14/01687, PI16/1288, PI17/00663, PI18/00909, PI18/01142, PI20/01695); from the UE (FP7-ENV-2011 cod 282,957 and HEALTH.2010.2.4.5–1); European Union’s Horizon 2020 research and innovation programme ATHLETE project (grant agreement 874583); from Miguel Servet-FEDER (CP11/00178, CP15/00025, and CPII16/00051, CPII18/00018); from Generalitat Valenciana: FISABIO (UGP 15–230, UGP-15–244, and UGP-15–249); from the Alicia Koplowitz Foundation 2017; from CIBERESP; from Fundación Cajastur and Universidad de Oviedo; from the Department of Health of the Basque Government (2005111093, 2009111069, 2,013,111,089 and 2015111065); from the Provincial Government of Gipuzkoa (DFG06/002, DFG08/001 and DFG15/221); annual agreements with the municipalities of the Gipuzkoa study area (Zumarraga, Urretxu, Legazpi, Azkoitia y Azpeitia y Beasain); and from Generalitat de Catalunya-CIRIT 1999SGR 00241. We received funding from the Agence Nationale de Securite Sanitaire de l’Alimentation de l’Environnement et du Travail (EST-18 RF-25), acknowledge support from the grant CEX2018-000806-S funded by MCIN/AEI/10.13039/501100011033 and support from the Generalitat de Catalunya through the CERCA Program. Laura Granés was funded by a Rio Hortega fellowship (CM22/00011) awarded by the Spanish Institute of Health Carlos III. Scott Delaney’s research contribution reported in this publication was supported by the National Institute of Environmental Health Sciences under Award Number R01ES034373 and by the National Institute on Aging under Award Number R01AG066793. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Joan Ballester acknowledges funding from the Spanish Ministry of Science and Innovation under grant agreement No RYC2018-025446-I (programme Ramón y Cajal).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Urban environment during pregnancy and childhood and white matter microstructure in preadolescence in two European birth cohorts

  • Binter, Anne-Claire
  • Granés, Laura
  • Bannier, Elise
  • Castro, Montserrat de
  • Petricola, Sami
  • Fossati, Serena
  • Vrijheid, Martine
  • Chevrier, Cécile
  • El Marroun, Hanan
  • Nieuwenhuijsen, Mark
  • Saint-Amour, Dave
  • Tiemeier, Henning
  • Guxens Junyent, Mònica
Growing evidence suggests that urban environment may influence cognition and behavior in children, but the underlying pollutant and neurobiological mechanisms are unclear. We evaluated the association of built environment and urban natural space indicators during pregnancy and childhood with brain white matter microstructure in preadolescents, and examined the potential mediating role of air pollution and road-traffic noise. We used data of the Generation R Study, a population-based birth cohort in Rotterdam, the Netherlands (n = 2725; 2002-2006) for the primary analyses. Replication of the main findings was attempted on an independent neuroimaging dataset from the PELAGIE birth cohort, France (n = 95; 2002-2006). We assessed exposures to 12 built environment and 4 urban natural spaces indicators from conception up to 9 years of age. We computed 2 white matter microstructure outcomes (i.e., average of fractional anisotropy (FA) and mean diffusivity (MD) from 12 white matte tracts) from diffusion tensor imaging data. Greater distance to the nearest major green space during pregnancy was associated with higher whole-brain FA (0.001 (95%CI 0.000; 0.002) per 7 m increase), and higher land use diversity during childhood was associated with lower whole-brain MD (-0.001 (95%CI -0.002; -0.000) per 0.12-point increase), with no evidence of mediation by air pollution nor road-traffic noise. Higher percentage of transport and lower surrounding greenness during pregnancy were associated with lower whole-brain FA, and road-traffic noise mediated 19% and 52% of these associations, respectively. We found estimates in the same direction in the PELAGIE cohort, although confidence intervals were larger and included the null. This study suggests an association between urban environment and white matter microstructure, mainly through road-traffic noise, indicating that greater access to green space nearby might promote white matter development., We gratefully acknowledge the contribution of the children and parents, general practitioners, hospitals, midwives and pharmacies in Rotterdam for their participation in the Generation R Study. The Generation R Study is conducted by the Erasmus Medical Center in close collaboration with the School of Law and Faculty of Social Sciences of the Erasmus University Rotterdam, Rotterdam; the Municipal Health Service Rotterdam Area, Rotterdam; the Rotterdam Homecare Foundation, Rotterdam; and the Stichting Trombosedienst and Artsenlaboratorium Rijnmond (STAR-MDC), Rotterdam. The general design of the Generation R Study is made possible by financial support from the Erasmus Medical Center, Rotterdam; the Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw); the Netherlands Organization for Scientific Research (NWO); and the Ministry of Health, Welfare and Sport. Air pollution exposure assessment was made possible by funding from the European Community's Seventh Framework Program (Grant Agreement no. 211250, Grant Agreement no. 243406). In addition, the study was made possible by financial support from the ZonMw (Geestkracht Program 10.000.1003 and TOP 40-00812-98-11021). Supercomputing resources for neuroimaging data processing were provided by the Dutch Organization for Scientific Research (NWO, Cartesius/Snellius). Dr. El Marroun was supported by Stichting Volksbond Rotterdam, the Netherlands Organization for Scientific Research (NWO) Aspasia grant (No: 015.016.056), and the European Union's Horizon Research and Innovation Program (HappyMums, Grant Agreement No: 101057390. We are grateful to the gynecologists, obstetricians, ultra-sonographers, midwives, pediatricians, and families who participated in the PELAGIE cohort study. The PELAGIE cohort has been funded by Inserm (since the beginning), the French Ministries of Health (2003–2004), Labor (2002–2003), and Research (ATC 2003–2004), the French National Institute for Public Health Surveillance (InVS, 2002–2006), the National Agency for Research (ANR, 2005–2008, 2010–2012, 2015–2019), the French Agency for Environmental Health Safety (Afsset/ANSES, 2007–2009, 2009–2012), the French Agency for Drug Safety (2013–2017), the Fondation de France (2014–2017, 2015–2018, 2017–2021), the French Ministry of Ecology (PNRPE 2014–2016), the Research Institute of Public Health (IResP 2011–2014), and the following European programs: Hi-WATE 2007–2009, ENRIECO 2008–2010, and OBERON 2019–2023. MRI data acquisition was performed at the Neurinfo MRI research facility of the University of Rennes I. Neurinfo is granted by the European Union (FEDER), the French State, the Brittany Council, Rennes Metropole, INRIA, Inserm, and the University Hospital of Rennes. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No 874583, Advancing Tools for Human Early Lifecourse Exposome research and Translation (ATHLETE). This publication reflects only the authors' view and the European Commission is not responsible for any use that may be made of the information it contains. The geocodification of the addresses and the estimation of the air pollutants of the Dutch study participants was done within the framework of a project funded by the Health Effects Institute (HEI) (Assistance Award No. R-82811201). L.G. was funded by a Rio Hortega fellowship (CM22/00011) and M.G. by a Miguel Servet II fellowship (CPII18/00018) both awarded by the Spanish Institute of Health Carlos III We acknowledge support from the European Union's Horizon 2020 research and innovation program under grant agreements No 824989 (EUCAN-Connect), and No 733206 (LifeCycle project). ISGlobal acknowledges support from the grant CEX2018-000806-S funded by MCIN/AEI/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program.